phloretin has been researched along with empagliflozin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dagar, N; Gaikwad, AB; Habshi, T; Kale, A; Shelke, V | 1 |
1 other study(ies) available for phloretin and empagliflozin
| Article | Year |
|---|---|
Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury.
Topics: Acute Kidney Injury; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ischemia; Male; Phloretin; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Toll-Like Receptor 4 | 2023 |